Apg Asset Management N.V. United Therapeutics Corp Transaction History

Apg Asset Management N.V.

$61 Billion
Q1 2024

A detailed history of Apg Asset Management N.V. transactions in United Therapeutics Corp stock. As of the latest transaction made, Apg Asset Management N.V. holds 118,242 shares of UTHR stock, worth $37.5 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

118,242

Previous 101,362 16.65%

Holding current value

$37.5 Million

Previous $22.3 Million 21.87%

% of portfolio

0.04%

Previous 0.04%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$210.76 - $249.51 $3.56 Million - $4.21 Million	16,880 Added 16.65%	118,242 $27.2 Million
Q4 2023 Feb 13, 2024	BUY	$214.88 - $256.94 $1.23 Million - $1.47 Million	5,716 Added 5.98%	101,362 $22.3 Million
Q3 2023 Nov 14, 2023	SELL	$211.82 - $248.24 $568,736 - $666,524	-2,685 Reduced 2.73%	95,646 $21.6 Million
Q2 2023 Aug 14, 2023	BUY	$205.19 - $232.99 $12.2 Million - $13.9 Million	59,526 Added 153.4%	98,331 $21.7 Million
Q1 2023 May 12, 2023	BUY	$212.99 - $276.17 $8.27 Million - $10.7 Million	38,805 New	38,805 $8.69 Million

Q3 2021 Nov 15, 2021	SELL	$179.86 - $214.88 $1.17 Million - $1.4 Million	-6,500 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$170.47 - $211.93 $1.38 Million - $1.72 Million	-8,100 Reduced 55.48%	6,500 $983,000
Q1 2021 May 14, 2021	BUY	$153.94 - $174.85 $2.25 Million - $2.55 Million	14,600 New	14,600 $2.08 Million
Q3 2020 Nov 12, 2020	SELL	$99.9 - $121.13 $2.44 Million - $2.96 Million	-24,409 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$92.74 - $125.82 $69.3 Million - $94 Million	-747,191 Reduced 96.84%	24,409 $2.63 Million
Q1 2020 May 14, 2020	BUY	$79.39 - $115.35 $61.3 Million - $89 Million	771,600 New	771,600 $80.7 Million
Q4 2019 Feb 13, 2020	SELL	$78.31 - $95.34 $798,527 - $972,181	-10,197 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$74.85 - $85.99 $3.88 Million - $4.45 Million	-51,803 Reduced 83.55%	10,197 $746,000
Q2 2019 Aug 13, 2019	SELL	$76.06 - $120.81 $54 Million - $85.7 Million	-709,600 Reduced 91.96%	62,000 $4.25 Million
Q1 2019 May 14, 2019	BUY	$107.15 - $126.84 $9.34 Million - $11.1 Million	87,200 Added 12.74%	771,600 $80.7 Million
Q4 2018 Feb 13, 2019	BUY	$101.4 - $128.73 $1.24 Million - $1.57 Million	12,200 Added 1.81%	684,400 $65.2 Million
Q3 2018 Nov 09, 2018	BUY	$113.81 - $129.46 $136,572 - $155,352	1,200 Added 0.18%	672,200 $74 Million
Q2 2018 Aug 13, 2018	SELL	$101.14 - $118.31 $748,436 - $875,494	-7,400 Reduced 1.09%	671,000 $65 Million
Q1 2018 May 14, 2018	SELL	$107.21 - $151.94 $2.95 Million - $4.18 Million	-27,500 Reduced 3.9%	678,400 $62 Million
Q4 2017 Jan 24, 2018	BUY	$118.58 - $151.28 $6.39 Million - $8.15 Million	53,900 Added 8.27%	705,900 $87 Million
Q3 2017 Oct 19, 2017	BUY	$114.6 - $136.81 $74.7 Million - $89.2 Million	652,000	652,000 $76.4 Million

Others Institutions Holding UTHR

# of Institutions

561

Shares Held

43.1M

Call Options Held

501K

Put Options Held

529K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $14.4B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Apg Asset Management N.V. with notifications on news.

Account

Apg Asset Management N.V. United Therapeutics Corp Transaction History